基于尿胱抑素C的急性肾损伤亚分期在危重患儿中的结局
这项多中心队列研究纳入中国四家三级医院PICU的793例患儿,按入PICU时尿胱抑素C(uCysC)水平分为非AKI、亚AKI及AKI亚分期A、B。亚AKI定义为未达KDIGO AKI标准但uCysC≥1.26 mg/g uCr;达KDIGO标准者uCysC<1.26为亚分期A、≥1.26为亚分期B。15.6%(124/793)符合亚AKI,22.7%(180/793)为AKI,其中50%(90/180)为亚分期B。校正混杂因素后,亚AKI(校正HR=2.42)和亚分期B(校正HR=2.83)与30天PICU死亡显著相关;亚分期B死亡风险高于亚AKI(HR=3.10)和亚分期A(HR=3.19)。提示uCysC有助于在KDIGO标准之外识别高危患儿。
要点
- 入PICU时uCysC≥1.26 mg/g uCr但未达KDIGO AKI标准者定义为亚AKI,占15.6%(124/793),校正后30天死亡HR=2.42。
- 达KDIGO AKI标准且uCysC≥1.26 mg/g uCr为AKI亚分期B,占AKI患者的50%(90/180),校正后死亡HR=2.83。
- 亚分期B死亡风险高于亚AKI(HR=3.10)和亚分期A(HR=3.19),且更易为经典AKI 3期。
- 亚AKI的死亡风险接近AKI亚分期A,提示uCysC可在KDIGO标准之外识别高危患儿。
适用人群与场景
- 中国四家三级医院PICU的危重患儿,共793例,按入PICU时uCysC水平分类。
诊断标准与关键阈值
- 亚AKI:入PICU时uCysC≥1.26 mg/g uCr且不符合KDIGO AKI标准。
- AKI亚分期A:符合KDIGO AKI标准且uCysC<1.26 mg/g uCr。
- AKI亚分期B:符合KDIGO AKI标准且uCysC≥1.26 mg/g uCr。
研究设计与关键结果
- 多中心队列研究,纳入中国四家三级医院PICU的793例患儿,按入PICU时uCysC水平分为非AKI、亚AKI及AKI亚分期A、B。
- 15.6%(124/793)符合亚AKI定义;22.7%(180/793)符合AKI,其中50%(90/180)为uCysC阳性AKI亚分期B,且亚分期B较亚分期A更易为经典AKI 3期。
- 与非AKI相比,亚AKI及AKI亚分期A、B均为与死亡显著相关的危险因素;校正混杂因素后,亚AKI(校正HR=2.42)和亚分期B(校正HR=2.83)与死亡的关联仍显著。
- 亚分期B较亚AKI死亡风险升高(HR=3.10),较亚分期A死亡风险升高(HR=3.19)。
证据类型、等级与局限
- 证据类型:多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于uCysC定义的亚AKI发生在20.2%的无AKI患者中,其死亡风险接近AKI亚分期A;uCysC阳性AKI亚分期B发生在50%的AKI患者中,更易为经典AKI 3期且死亡风险最高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The concept of acute kidney injury (AKI) substages has been recommended to better phenotype AKI and identify high-risk patient groups and therefore improve the diagnostic accuracy of AKI. However, there remains a gap between the recommendation and the clinical application. The study aimed to explore the incidence of AKI substages based on a sensitive AKI biomarker of urinary cystatin C (uCysC), and to determine whether AKI substages were relevant with respect to outcome in critically ill children.
RESULTS: The multicenter cohort study enrolled 793 children in pediatric intensive care unit (PICU) of four tertiary hospitals in China. Children were classified as non-AKI, sub-AKI and AKI substages A and B according to uCysC level at PICU admission. Sub-AKI was defined by admission uCysC level ≥ 1.26 mg/g uCr in children not meeting the KDIGO criteria of AKI. In children who fulfilled KDIGO criteria, those with uCysC < 1.26 was defined as AKI substage A, and with ≥ 1.26 defined as AKI substage B. The associations of AKI substages with 30-day PICU mortality were assessed. 15.6% (124/793) of patients met the definition of sub-AKI. Of 180 (22.7%) patients with AKI, 90 (50%) had uCysC-positive AKI substage B and were more likely to have classical AKI stage 3, compared to substage A. Compared to non-AKI, sub-AKI and AKI substages A and B were risk factors significantly associated with mortality, and the association of sub-AKI (adjusted hazard ratio HR = 2.42) and AKI substage B (adjusted HR = 2.83) with mortality remained significant after adjustment for confounders. Moreover, AKI substage B had increased risks of death as compared with sub-AKI (HR = 3.10) and AKI substage A (HR = 3.19).
CONCLUSIONS: Sub-AKI defined/based on uCysC occurred in 20.2% of patients without AKI and was associated with a risk of death close to patients with AKI substage A. Urinary CysC-positive AKI substage B occurred in 50% of AKI patients and was more likely to have classical AKI stage 3 and was associated with the highest risk of mortality.
参考来源
- Chen J, Jiang Z, Huang H, et al. The outcome of acute kidney injury substages based on urinary cystatin C in critically ill children. Ann Intensive Care. 2023. PMID: 36976367. doi:10.1186/s13613-023-01119-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。